Promaxo, IncMay 17, 2021 8:05 pm
Promaxo is developing an office-based, portable MRI with cellular spatial resolution, and real-time targeted biopsy and treatment tools for the urology market. Our current focus is on transforming prostate cancer disease management. Promaxo’s patented MR technology takes advantage of proprietary ultra-fast and strong gradients and pre-polarization fields which can be switched on rapidly without causing bio-effects (e.g., nerve stimulation). The prototype MRI systems have demonstrated rise- and fall-times about one-hundred times faster than conventional MRI. These rapid and strong gradients (about 10 T/m) permit collection of millions of points in k-space in tens of seconds, yielding images with spatial resolution of 30 microns, comparable to histology.
This post was written by user